Human Molecular Genetics, Vol 7, 335-345, Copyright © 1998 by Oxford University Press
DH Gutmann, RT Geist, Hm Xu, JS Kim and S Saporito-Irwin
Neurofibromatosis 2 (NF2) is an inherited cancer syndrome resulting from
mutations in the NF2 tumor suppressor gene. Analysis of NF2 mutations has
revealed some general genotype-phenotype correlations. Severe disease has
been associated with mutations that produce a premature termination while
more mild disease has been associated with missense mutations. Here, we
provide experimental proof for these genotype-phenotype correlations by
demonstrating that nonsense mutations fail to produce stable merlin protein
while missense mutations result in the generation of merlin proteins
defective in negative growth regulation. This inability to suppress cell
growth may result from defects in the function of merlin at several levels,
including failure to form an intramolecular complex. Based on these
findings, we propose a model for merlin growth suppression that provides a
framework for analyzing NF2 patient mutations and merlin function.
ARTICLES
Defects in neurofibromatosis 2 protein function can arise at multiple levels
Department of Neurology, Washington University School of Medicine, St Louis, MO 63110, USA. gutmannd@neuro.wustl.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. J. Dickinson, E. I. Surace, M. Cambell, R. J. Higgins, C. M. Leutenegger, A. W. Bollen, R. A. LeCouteur, and D. H. Gutmann Expression of the Tumor Suppressor Genes NF2, 4.1B, and TSLC1 in Canine Meningiomas Vet. Pathol., September 1, 2009; 46(5): 884 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Houshmandi, R. J. Emnett, M. Giovannini, and D. H. Gutmann The Neurofibromatosis 2 Protein, Merlin, Regulates Glial Cell Growth in an ErbB2- and Src-Dependent Manner Mol. Cell. Biol., March 15, 2009; 29(6): 1472 - 1486. [Abstract] [Full Text] [PDF] |
||||
![]() |
M E Baser, L Kuramoto, R Woods, H Joe, J M Friedman, A J Wallace, R T Ramsden, S Olschwang, E Bijlsma, M Kalamarides, et al. The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2 J. Med. Genet., July 1, 2005; 42(7): 540 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rong, X. Tang, D. H. Gutmann, and K. Ye Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L PNAS, December 28, 2004; 101(52): 18200 - 18205. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lallemand, M. Curto, I. Saotome, M. Giovannini, and A. I. McClatchey NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions Genes & Dev., May 1, 2003; 17(9): 1090 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-X. Sun, C. Haipek, D. R. Scoles, S. M. Pulst, M. Giovannini, M. Komada, and D. H. Gutmann Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate Hum. Mol. Genet., December 1, 2002; 11(25): 3167 - 3178. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Sperfeld, C. Hein, J. M. Schroder, A. C. Ludolph, and C. O. Hanemann Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2 Brain, May 1, 2002; 125(5): 996 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. M. Schulze, C. O. Hanemann, H. W. Muller, and H. Hanenberg Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis Hum. Mol. Genet., January 1, 2002; 11(1): 69 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Gutmann, A. C. Hirbe, and C. A. Haipek Functional analysis of neurofibromatosis 2 (NF2) missense mutations Hum. Mol. Genet., July 1, 2001; 10(14): 1519 - 1529. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Morrison, L. S. Sherman, J. Legg, F. Banine, C. Isacke, C. A. Haipek, D. H. Gutmann, H. Ponta, and P. Herrlich The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44 Genes & Dev., April 15, 2001; 15(8): 968 - 980. [Abstract] [Full Text] |
||||
![]() |
D. H. Gutmann The neurofibromatoses: when less is more Hum. Mol. Genet., April 1, 2001; 10(7): 747 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Gutmann, C. A. Haipek, S. P. Burke, C.-X. Sun, D. R. Scoles, and S. M. Pulst The NF2 interactor, hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), associates with merlin in the 'open' conformation and suppresses cell growth and motility Hum. Mol. Genet., April 1, 2001; 10(8): 825 - 834. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Brault, A Gautreau, M Lamarine, I Callebaut, G Thomas, and L Goutebroze Normal membrane localization and actin association of the NF2 tumor suppressor protein are dependent on folding of its N-terminal domain J. Cell Sci., January 5, 2001; 114(10): 1901 - 1912. [Abstract] [PDF] |
||||
![]() |
D G. R Evans, M Sainio, and M. E Baser Neurofibromatosis type 2 J. Med. Genet., December 1, 2000; 37(12): 897 - 904. [Abstract] [Full Text] |
||||
![]() |
D. R. Scoles, D. P. Huynh, M. S. Chen, S. P. Burke, D. H. Gutmann, and S.-M. Pulst The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate Hum. Mol. Genet., July 1, 2000; 9(11): 1567 - 1574. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Goutebroze, E. Brault, C. Muchardt, J. Camonis, and G. Thomas Cloning and Characterization of SCHIP-1, a Novel Protein Interacting Specifically with Spliced Isoforms and Naturally Occurring Mutant NF2 Proteins Mol. Cell. Biol., March 1, 2000; 20(5): 1699 - 1712. [Abstract] [Full Text] |
||||
![]() |
C. LÓPEZ-CORREA, J. ZUCMAN-ROSSI, H. BREMS, G. THOMAS, and E. LEGIUS NF2 gene deletion in a family with a mild phenotype J. Med. Genet., January 1, 2000; 37(1): 75 - 77. [Full Text] |
||||
![]() |
M. Giovannini, E. Robanus-Maandag, M. Niwa-Kawakita, M. van der Valk, J. M. Woodruff, L. Goutebroze, P. Mérel, A. Berns, and G. Thomas Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein Genes & Dev., April 15, 1999; 13(8): 978 - 986. [Abstract] [Full Text] |
||||







